Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013

  Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on
                               November 7, 2013

Conference Call and Webcast to Follow

PR Newswire

WASHINGTON, Oct. 21, 2013

WASHINGTON, Oct. 21, 2013 /PRNewswire/ --Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA), a biopharmaceutical company focused on the development and
commercialization of products for the treatment of central nervous system
disorders, today announced it will release results for the third quarter of
2013 on Thursday, November 7, 2013, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, November
7, 2013, during which Vanda management will discuss the financial results. To
participate in the conference call, please dial 1-888-895-5271 (domestic) or
1-847-619-6547 (international) and use passcode 35919679.

The conference call will be broadcast simultaneously and archived on the
Company's website, www.vandapharma.com. Investors should go to the website at
least 15 minutes early to register, download, and install any necessary audio
software.

A replay of the call will be available on Thursday, November 7, 2013,
beginning at 12:00 PM ET and will be accessible until Thursday, November 14,
2013, at 5:00 PM ET. The replay call-in number is 1-888-843-7419 for domestic
callers and 1-630-652-3042 for international callers. The passcode number is
35919679.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of products for the treatment of central
nervous system disorders. For more on Vanda Pharmaceuticals Inc., please
visit www.vandapharma.com. 

Investor Contact:
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@troutgroup.com

SOURCE Vanda Pharmaceuticals Inc.

Website: http://www.vandapharma.com
 
Press spacebar to pause and continue. Press esc to stop.